메뉴 건너뛰기
BJU International
Volumn 96, Issue 7, 2005, Pages 954-956
Revisiting my personal decision about prostate-specific antigen testing in 2005
Author keywords

[No Author keywords available]
Indexed keywords

PROSTATE SPECIFIC ANTIGEN;
EID: 27444442095     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05796.x     Document Type: Note
Times cited : (4)
References (8)
  • 1
    • 27444438915 scopus 로고    scopus 로고
    • United States physicians and their personal prostate cancer screening practices with prostate specific antigen
    • in press
    • Chan ECY, Barry MJ, Vernon SW, Ahn C. United States physicians and their personal prostate cancer screening practices with prostate specific antigen. J Gen Intern Med 2005; in press
    • (2005) J Gen Intern Med
    • Chan, E.C.Y.1    Barry, M.J.2    Vernon, S.W.3    Ahn, C.4
  • 2
    • 21044453581 scopus 로고    scopus 로고
    • Radical prostatectomy versus watchful waiting in early prostate cancer
    • Bill-Axelson A, Homberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. New Engl J Med 2005; 352: 1977-84
    • (2005) New Engl J Med , vol.352 , pp. 1977-1984
    • Bill-Axelson, A.1    Homberg, L.2    Ruutu, M.3
  • 3
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • D'Amico AV, Chen M, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. New Engl J Med 2004; 35: 125-35
    • (2004) New Engl J Med , vol.35 , pp. 125-135
    • D'Amico, A.V.1    Chen, M.2    Roehl, K.A.3    Catalona, W.J.4
  • 4
    • 84863035912 scopus 로고    scopus 로고
    • National Cancer Institute. SEER Cancer Statistics Review, http://seer.cancer.gov/ csr/1975_2002/results_merged/ topic_lifetime_risk.pdf [Accessed July 2005]
    • SEER Cancer Statistics Review
  • 5
    • 21444447966 scopus 로고    scopus 로고
    • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower
    • Thompson IM, Ankerst DP, Chi C et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. JAMA 2005; 294: 66-70
    • (2005) JAMA , vol.294 , pp. 66-70
    • Thompson, I.M.1    Ankerst, D.P.2    Chi, C.3
  • 6
    • 8344250133 scopus 로고    scopus 로고
    • Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result
    • McNaughton-Collins M, Fowler FJ Jr, Caubet JF et al. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med 2004; 117: 719-25
    • (2004) Am J Med , vol.117 , pp. 719-725
    • McNaughton-Collins, M.1    Fowler Jr., F.J.2    Caubet, J.F.3
  • 7
    • 14944338731 scopus 로고    scopus 로고
    • Selenium and vitamin e cancer prevention trial
    • Klein EA. Selenium and vitamin E cancer prevention trial. Ann NY Acad Sci 2004; 1031: 234-41
    • (2004) Ann NY Acad Sci , vol.1031 , pp. 234-241
    • Klein, E.A.1
  • 8
    • 8644221362 scopus 로고    scopus 로고
    • Alcohol consumption and the risk of prostate cancer in middle-aged men
    • Schoonen WM, Saunas CA, Kiemeny LA, Stanford JL Alcohol consumption and the risk of prostate cancer in middle-aged men. Int J Cancer 2005; 113: 133-40
    • (2005) Int J Cancer , vol.113 , pp. 133-140
    • Schoonen, W.M.1    Saunas, C.A.2    Kiemeny, L.A.3    Stanford, J.L.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.